Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides

Henrik Toft Sørensen1, Mette Vinther Skriver, Lars Pedersen

  • 1Department of Clinical Epidemiology, Aarhus University Hospital and Aalborg Hospital, Aarhus, Denmark. hts@soci.au.dk

Insights

Macrolide antibiotics transmitted via breast milk may increase the risk of infantile hypertrophic pyloric stenosis in newborns. This finding highlights potential risks associated with breastfeeding after maternal macrolide exposure.

Area of Science:

  • Neonatal health
  • Pharmacology
  • Pediatric gastroenterology

Background:

  • A previous case report suggested a link between erythromycin in breast milk and infantile hypertrophic pyloric stenosis (IHPS).
  • Macrolide antibiotics are commonly prescribed and can be transmitted to infants through breast milk.

Purpose of the Study:

  • To investigate the association between maternal macrolide use during breastfeeding and the risk of infantile hypertrophic pyloric stenosis (IHPS) in neonates.

Main Methods:

  • A population-based cohort study utilizing Danish prescription, birth, and hospital discharge registries.
  • Included 1166 women prescribed macrolides from birth to 90 days postpartum and 34,690-41,778 control women.
  • Analyzed odds ratios for IHPS based on postnatal macrolide exposure, stratified by infant gender.

Main Results:

  • Macrolide use during breastfeeding was associated with an increased risk of IHPS.
  • Odds ratios ranged from 2.3 to 3.0 for different postnatal exposure periods.
  • Gender-specific analysis showed a significantly higher risk in girls (OR 10.3) compared to boys (OR 2.0).

Conclusions:

  • Maternal macrolide use while breastfeeding elevates the risk of infantile hypertrophic pyloric stenosis in neonates.
  • The association appears stronger in female infants.
  • This study underscores the importance of considering antibiotic exposure risks during breastfeeding.

Related Concept Videos

Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Pyloric Obstruction01:11

Pyloric Obstruction

Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...